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Abstract
Picomolar concentrations of proteins comprising only the N-terminal 70-kDa region (70K) of fibronectin (FN) stimulate cell
migration into collagen gels. The Ile-Gly-Asp (IGD) motifs in four of the nine FN type 1 (FNI) modules in 70K are important for
such migratory stimulating activity. The 70K region mediates binding of nanomolar concentrations of intact FN to cell-









9FNI. Wildtype 70K and 70K with Ile-to-Ala mutations were equally active in
binding to assembly sites of FN-null fibroblasts. This finding indicates that IGD motifs do not mediate the interaction
between 70K and the cell-surface that is important for FN assembly. Further, FN fragment N-
3FNIII, which does not stimulate
migration, binds to assembly sites on FN-null fibroblast. The Ile-to-Ala mutations had effects on the structure of FNI modules
as evidenced by decreases in abilities of 70K with Ile-to-Ala mutations to bind to monoclonal antibody 5C3, which
recognizes an epitope in
9FNI, or to bind to FUD, a polypeptide based on the F1 adhesin of Streptococcus pyogenes that
interacts with 70K by the b-zipper mechanism. These results suggest that the picomolar interactions of 70K with cells that
stimulate cell migration require different conformations of FNI modules than the nanomolar interactions required for
assembly.
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Introduction
Fibronectin (FN) is a large glycoprotein distributed widely in the
body. It is an insoluble component of the extracellular matrix,
where it plays a role in cell adhesion, migration, and embryogen-
esis [1,2]. It is also present at near micromolar concentrations in
plasma [3], from which it is deposited in fibrin and assembled on
the surface of platelets and thus contributes to the growth and
stability of thrombi [4,5]. FN is a disulfide-linked dimer of subunits
comprising 12 type 1 (FNI) modules, two type 2 (FNII), and 15–17
type 3 (FNIII) modules [2] (Fig. 1A). Nine of the FNI modules
along with the two FNII modules are found in the N-terminal 70-
kDa region of FN (70K) (Fig. 1A). This part of FN, as a proteolytic
fragment or truncated FN splice variant that also includes part of
1FNIII and 10 amino acids encoded by an intron, stimulates cell
migration into collagen gels at picomolar concentrations and is
called migration-stimulating factor (MSF) (Fig. 1A) [6,7]. The
MSF splice variant of FN is expressed in fetal and cancer
fibroblasts and tumor associated macrophages and endothelial
cells [6,8].
FNI modules adopt a characteristic fold with a minor b-sheet (A
and B strands), a major b-sheet (C, D, and E strands), two
conserved disulfide bonds, and a hydrophobic core containing a
conserved tyrosine and tryptophan [9]. The ability of MSF to
stimulate fibroblast migration into collagen gels has been
attributed to Ile-Gly-Asp (IGD) motifs found in loops between B




9FNI [10,11]. Although it
was deduced originally that IGD motifs in
7FNI and
9FNI are
responsible for the migratory effect, N-
5FNI (Fig. 1A) stimulates
fibroblast migration in the presence of vitronectin or serum,
indicating that the IGD motifs in
3FNI and
5FNI are also sufficient
for MSF activity [10,12].
Consecutive FNI modules are arranged ‘‘tail-to-head’’ in a way
that allows otherwise unstructured regions of bacterial surface
proteins to interact with the E-strands of consecutive modules by
anti-parallel b-strand addition, an unusual type of protein-protein
interaction that has been termed b-zipper formation
[13,14,15,16]. The 70K region also directs binding of FN at
nanomolar concentrations to sites on the cell-surface to facilitate
FN assembly into insoluble fibrils [17,18,19]. In addition, as a
fragment, 70K, at nanomolar concentrations, binds to these sites
and blocks FN assembly [20]. Remarkably, at the same
concentration range that 70K is effective at inhibiting FN
assembly, it is inactive in stimulating fibroblast cell migration,
i.e., the dose response curve for 70K in the migration assay is
bimodal, peaking at ,15–150 pM and inactive at ,1.5 nM [7].
We have speculated that b-zipper formation may localize the 70K
region of FN to assembly sites based on observations that a 56-
residue recombinant polypeptide inspired by the ‘‘Functional
Upstream Domain’’ (FUD) of the F1 adhesin in Streptococcus pyogenes
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e30615uses this mechanism to bind to the 70K region of FN with low
nanomolar affinity and in so doing blocks FN assembly [14,21].
Here we compare binding to FN assembly sites and to FUD of
wildtype 70K and 70K harboring isoleucine-to-alanine (Ile-to-Ala)








9FNI modules. We conclude that mutations
in IGD motifs do not grossly impair the nanomolar affinity
interaction between 70K and assembly sites on fibroblasts. In
contrast, the Ile-to-Ala mutations alter binding of a monoclonal
antibody (mAb) directed towards an epitope in
9FNI. These results
raise the possibility that mutations of the IGD motifs cause
structural changes in FNI modules that impair the picomolar
interactions of 70K with the cell components that mediate MSF
activity.
Results
Expression of 70K with mutations in IGD motif
Previous migration studies focused on the IGD motif of
7–9FNI
or
8–9FNI expressed in Pichia pastoris showed that Ile-to-Ala
mutations in
7FNI and
9FNI resulted in loss of MSF activity of the
tandem FNI constructs whereas constructs with an intact IGD
motif were active [10]. To examine the role of IGD motifs in
binding to cell surface sites for FN assembly, we created
recombinant 70K proteins in baculovirus containing Ile-to-Ala










Mutations in IGD motif do not alter 70K binding
To determine the effect of mutations in IGD motifs on 70K
binding to FN-null (FN
2/2) fibroblasts, cells adherent to adsorbed
FN were provided 40 nM FITC-70K, FITC-70K I150/242A,
FITC-70K I480/572A, or FITC-70K I150/242/480/572A, a
concentration of 70K that saturates ,80% of binding sites on the
cell surface [22]. All proteins bound to the surface of FN
2/2
fibroblast in fibrillar arrays as seen by microscopy (Fig. 2A).
Western blotting corroborated the impression from microscopy
that similar quantities of the proteins bound to the cell layers
(Fig. 2B). These results indicate that intact IGD motifs are not
required for binding of 70K to cell-surface assembly sites.
N-
3FNIII binds to the cell-surface
Previous studies have shown that 70K, but not N-
3FNIII,
stimulates fibroblast migration [7]. The inability of N-
3FNIII to
stimulate fibroblast migration has been attributed to a salt bridge
between Arg222 in
4FNI and residues in
3FNIII that causes
N-
3FNIII to fold back on itself, thus occluding IGD motifs in
7FNI
and
9FNI [7]. To look for other differences between binding to cell
surface assembly sites and MSF activity, we tested the ability of
N-




1FNIII-C EDA+ coated coverslips were provided 30 nM
N-
3FNIII or FN (molarity based on the subunit) and stimulated
with 200 nM lysophosphatidic acid. After 3 h, cells were fixed and
stained with mouse-anti human antibody 5C3, which recognizes
9FNI [14]. As visualized by 5C3 staining, N-
3FNIII or FN bound
to FN
2/2 fibroblasts (Fig. 3).
Alteration of the epitope of mAb 5C3
Previous NMR studies comparing
8–9FNI structures with any of
seven different mutations in the IGD motif in
9FNI showed minor
changes in residues surrounding the mutations, and no changes in
the folds of the modules [10]. As another probe of structural
alterations, we used mAb 5C3, which binds Gly567 in the loop
between the A and B strands, five residues away from Ile572 in the
IGD motif [14]. In a competitive ELISA, increasing concentra-
tions of 70K or 70K I150/242A decreased binding of 5C3 to
coated FN; 30-fold higher concentrations of 70K I480/572A or
70K I150/242/480/572A were needed for the same effect
(Fig. 4A). In contrast, when we tested mAb 7D5 to an epitope in
the loop adjacent to the E-strand of
4FNI [14], 70K, 70K I150/
242A, 70K I480/572A, or 70K I150/242/480/572A decreased
antibody binding to coated FN at approximately equal concen-
trations (Fig. 4B). Thus, the I572A mutation causes structural
changes that are significant enough to alter the affinity of 5C3 that
binds in close proximity to the site of the mutation.
IGD mutations minimally alter bacterial peptide binding
The functional upstream domain is a 49-amino acid sequence
from the F1 adhesin in S. pyogenes that binds to 70K by b-strand
addition and inhibits FN matrix assembly [14,19,21]. To
determine if Ile-to-Ala mutations altered binding of FUD to
Figure 1. Diagram of FN and FN fragments and location of IGD motifs in 70K. (A) The EDA+, V89 splice variant subunit of FN is shown
consisting of 12 FNI modules (ovals), two FNII modules (diamonds), and 16 FNIII modules (squares). Plasma FN lacks EDA and one subunit contains a
variable region and the other subunit lacks it. Modules are numbered to facilitate naming recombinant proteins according to modular content. MSF is
the N-terminus through the sequence encoded by the
1FNIIIa exon and 10 intronic amino acids [6]. FNI modules containing IGD motifs are indicated
with an *. (B) Sequence of FUD with presumptive binding sites for FNI modules in bold and underlined and N- and C-terminal tails in lower case.
doi:10.1371/journal.pone.0030615.g001
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compete for binding of 0.3 nM biotinylated FUD (b-FUD) to
coated FN. Both I150/242A and 70K I480/572A had 2-fold
decreased ability to compete for binding of b-FUD to coated FN as
compared to wildtype 70K (Fig. 5A). 70K with all four Ile-to-Ala
mutations had an even greater decrease in its ability to compete
for b-FUD (Fig. 5A). To determine if the decreased affinity of b-
FUD for mutated 70K was specific for Ile-to-Ala mutations, we
compared the ability of human and rat 70K to compete for b-FUD
binding to FN. There are 30 residues that differ in the expressed
rat 70K protein as compared to the human protein [14]. However,
increasing concentrations of human 70K or rat 70K had the same
ability to compete for 0.3 nM b-FUD binding to coated FN
(Fig. 5B). Further, human 70K in which Asn-Gly-Arg (NGR)
motifs in
3FNI and
5FNI were mutated to Gln-Gly-Arg (QGR)
sequences [23] competed equally well as 70K for b-FUD binding
to coated FN (data not shown).
Discussion
The 70K fragment of FN binds to cell-surface FN assembly sites
with the same nanomolar affinity as full-length FN, and at a
thousand-fold lower picomolar concentration, 70K stimulates
migration of fibroblasts into type I collagen [7,22]. Full-length FN
and the N-
3FNIII construct lack MSF activity, probably because
Figure 2. 70K with Ile-to-Ala mutations bind to FN
2/2
fibroblasts. (A) FN
2/2 fibroblasts adherent to FN-coated coverslips
were provided 40 nM FITC-70K, FITC-70K I150/242A, FITC-70K I480/
572A, or FITC-70K I150/242/480/572A for 1 h before fluorescent
microscopic imaging of the FITC fluorochrome. Results are represen-
tative of multiple fields of each condition examined in four separate
experiments. Bar, 10 mm. (B) Western blot of cell lysates from cells
provided FITC-70K (1), FITC-70K I150/242A (2), FITC-70K I480/572A (3),
or FITC-70K I150/242/480/572A (4). The asterisk denotes the FITC-70K
band. The Western blot was probed with rabbit anti-FITC followed by
peroxidase-conjugated donkey anti-rabbit IgG.
doi:10.1371/journal.pone.0030615.g002
Figure 3. N-




1FNIII-C EDA+-coated coverslips were provided 30 nM
N-
3FNIII or FN subunit (15 nM dimeric FN) in the presence of 200 nM
LPA for 3 h, washed, fixed, and immunostained with the mAb 5C3
followed by rhodamine labeled secondary antibody. Bar, 10 mm.
doi:10.1371/journal.pone.0030615.g003
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PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e30615the sites required for the activity are obscured in the quaternary
structure [7,12]. The structure/function relations of the MSF
activity compared to FN assembly activity are not known. Because
migration stimulating ability of 70K has been shown to be
dependent on the IGD motifs [10,11], we investigated binding of








9FNI to the cell
surface as well as to mAbs and FUD polypeptide that bind to 70K
[14].
Ile-to-Ala mutations in either two or four IGD motifs in 70K did
not affect the binding of 70K to FN
2/2 fibroblasts and had
minimal effects on binding of FUD. These results contrast with
loss of MSF activity when isoleucine residues in the IGD motifs of
7FNI and
9FNI were mutated in a FN fragment containing
7–9FNI
[10]. The contrasting results indicate that the interactions with cell
surfaces that stimulate migration and enable FN assembly are
different. Additional evidence supporting the idea that the
interactions are different is provided by experiments showing that
N-
3FNIII binds to the cell-surface of FN
2/2 fibroblasts, whereas
N-
3FNIII does not stimulate migration [7]. Finally, a polypeptide
highly homologous to FUD has been demonstrated to enhance
rather than inhibit the ability of N-
3FNIII to stimulate migration
whereas FUD is an inhibitor of binding of 70K to fibroblast
assembly sites [19,24].
Signaling mediating MSF activity seems to involve inhibition of
AKT [25]. The cell-surface molecules that initiate such signaling
remain to be identified. Experiments blocking avb3 integrins with
antibodies indicate a role for this integrin in migration [11,12], but
whether avb3 interacts with MSF to initiate signaling or engages
binding sites in the supporting collagen gel to mediate migration is
not known. We are not aware of avb3 interacting with any ligands
with picomolar affinity. In addition, there is no evidence that the
nanomolar binding of 70K to the cell surface assembly sites is
dependent on avb3. A cyclic RGD peptide that inhibits avb3 cell
adhesive activity does not block binding of 70K at nanomolar
concentrations to the cell-surface [23]. Further, although NGR
motifs in
3FNI and
5FNI spontaneously convert to integrin-binding
isoDGR sequences, and isoDGR can interact with avb3 integrins
[26], the conversion of NGR to isoDGR is incomplete, and
Figure 4. Structural alterations in 70K with IGD mutations.
Binding relative to no competitor of 1:30,000 5C3 ascites (A) or 1:50,000
7D5 ascites (B) to coated FN in the presence of increasing concentration
of 70K (%), 70K I150/242A (n), 70K I480/572A (.), or 70K I150/242/480/
572A (¤). Values are mean plus/minus standard deviation of 3
experiments.
doi:10.1371/journal.pone.0030615.g004
Figure 5. 70K with Ile-to-Ala mutations compete less well for
binding of b-FUD to adsorbed FN. (A) Binding relative to no
competitor of 0.3 nM b-FUD to coated FN in the presence of increasing
concentrations of 70K (%), 70K I150/242A (n), 70K I480/572A (.), or
70K I150/242/480/572A (¤). (B) Binding relative to no competitor of
0.3 nM b-FUD to FN in the presence of increasing concentrations of
human 70K (%) or rat 70K (,). Values are mean plus/minus standard
deviation of 3 experiments.
doi:10.1371/journal.pone.0030615.g005
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PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e30615mutagenesis experiments indicate that the sequences are not
responsible for binding of 70K to assembly sites [23].
Previous NMR studies showed little structural alteration in
9FNI
with mutations in the IGD motif; these changes involved Ser575
and the disulfide connecting the A- and D-strands [10]. Our
results showed that the I572A mutation results in decreased
binding of mAb 5C3 to its epitope, which contains Gly567 five
amino acids away from Ile572. Further, mutations in the IGD
motif, but not the 30 differences between rat and human 70K or
mutations in NGR motifs, affected the ability of 70K to interact
with the bacterial peptide FUD. As with other FN-binding
sequences from bacteria [13,15,16], FUD appears to bind to the
E-strand of FNI modules [14]. Because the IGD sequence is in the
loop connecting B and C strands, it is unlikely that mutations in
IGD motifs interfere directly with FUD binding [12]. Instead,
because the conserved isoleucine is part of the hydrophobic core of
FNI modules [9], we hypothesize that the Ile-to-Ala mutations
disrupt the hydrophobic core of the FNI module which in turn
deforms the modules and alters the ability of FUD to bind. The
IGD motif is part of the sequence YX(I/V)G(D/E) found in nine
of 12 FNI modules. It is noteworthy that mutation of the tyrosine,
which is found in all 12 FNI modules and contributes to the
hydrophobic core[9], to serine in any of the five N-terminal FNI
modules is deleterious to secretion of 70K and binding of 70K to
matrix assembly sites or to Staphylococcus aureus [27], an interaction
that requires b-zipper formation.
The literature and present results present a conundrum. The
interaction leading to migration is not only orders of magnitude
tighter than described integrin-ligand interactions, but also orders
of magnitude tighter than the interaction of 70K to FUD or
assembly sites. Nevertheless, the MSF interaction apparently
involves recognition of a binding surface that can be presented by
any of four different FNI modules whereas the binding to assembly
sites or FUD involves simultaneous interactions with multiple FNI
modules. The attribute required for MSF activity may be the
display of the side chains of the IGD motifs on the surface of the
modules, as suggested by the MSF activity of micromolar
concentrations of IGD-containing tetrapeptides [11], or a
common structural feature of IGD-containing FNI modules that
requires the isoleucine.
Materials and Methods
Expression of recombinant proteins, purification of FN,
and antibodies
Recombinant human 70K (N-
9FNI) with I150/242A, I480/
572A, or I150/242/480/572A mutations and rat 70K were
produced using a baculovirus expression system with either High 5
or SF9 cells as described before [14,28]. Proteins were purified
over nickel-nitrilotriacetic acid agarose as previously described
except that in the case of the 70K proteins, proteins were
incubated with nickel-nitrilotriacetic acid agarose in the presence
of 15 mM imidazole [28,29]. Residues in 70K proteins are
numbered starting with the initiating methionine of FN. Thus, the
residue that we call Ile572 would be called Ile541 if numbering
were to start with the first residue after removal of FN’s pre-pro
sequence [7]. 70K proteins were stored in 10 mM Tris, 300 mM
NaCl, 1 M NaBr. Recombinant N-
3FNIII was expressed and
purified as described previously [14].
1FNIII-C EDA+ was
described previously [29]. Expression of FUD was described
previously [14]. The sequence of FUD is shown in Fig. 1B.
Human plasma FN was prepared by anion exchange chroma-
tography of a fibrinogen-rich fraction as described previously [30].
Mouse anti-human mAbs 7D5 and 5C3 were described previously
[14].
Labeling of 70K and FUD
70K was labeled with fluorescein-5-isothiocyanate (FITC)
(Invitrogen) as previously described [23]. FUD was biotinylated




2/2 mouse fibroblasts were derived from stem cells of FN
knockout mice as previously described [14,29]. For assembly
experiments, coverslips coated with 10 mg/mL FN (20 nM) or
3.8 mg/mL (10 nM)
1FNIII-C EDA+ were provided 70,000 cells
in 0.5 mL Dulbecco’s modified Eagle’s medium (DMEM,
Invitrogen) plus 0.2% bovine serum albumin (BSA) as described
previously except that cells were allowed to spread for 1 h before
the addition of 40 nM FITC-70K proteins for 1 h [14]. In
experiments comparing the deposition of N-
3FNIII or FN, cells
adherent to
1FNIII-C EDA+ were provided 30 nM N-
3FNIII or
30 nM FN (monomer, 15 nM dimer) with 200 nM lysopho-
sphatidic acid (LPA) for 3 h. Cells were fixed and immunostained
with 2 mg/mL 5C3 followed by rhodamine red-x donkey anti-
mouse IgG (Jackson ImmunoResearch). For Western blot, cells
were treated as above except that cells were grown in 24-well tissue
culture treated plates (Costar 3524) coated with 10 mg/mL FN.
Instead of fixation, cells were provided 40 mL SDS-PAGE sample
buffer containing 10% b-mercaptoethanol, incubated for 10 min,
and sample buffer was collected after forceful scraping. This was
repeated with 10 ml of sample buffer also containing 10% b-
mercaptoethanol. Samples were run on an 8% SDS-PAGE gels
and Western blot was done with rabbit anti-FITC (Molecular
Probes) and peroxidase-conjugated donkey anti-rabbit IgG
(Jackson ImmunoResearch) according to standard procedure
[29,31].
Enzyme-linked assay
Enzyme-linked assays were done using high binding plates
(Corning 3590) coated overnight at 4uC with 50 mlo f1 0mg/mL
FN. Assays were preformed as previously described [14]. Graphs
are of mean +/2 standard deviation of the mean of triplicates
from 3 separate experiments.
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